These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37638216)

  • 21. Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Meighani A; Hart BR; Bourgi K; Miller N; John A; Ramesh M
    Dig Dis Sci; 2017 Oct; 62(10):2870-2875. PubMed ID: 28451916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of Gastrointestinal Infections After Initiating Vedolizumab and Anti-TNFα Agents for Ulcerative Colitis.
    Dalal RS; Mitri J; Goodrick H; Allegretti JR
    J Clin Gastroenterol; 2023 Aug; 57(7):714-720. PubMed ID: 36156528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
    Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease.
    Hanada Y; Khanna S; Loftus EV; Raffals LE; Pardi DS
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):528-533. PubMed ID: 29037938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
    Nitzan O; Elias M; Chazan B; Raz R; Saliba W
    World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease.
    Ananthakrishnan AN; Guzman-Perez R; Gainer V; Cai T; Churchill S; Kohane I; Plenge RM; Murphy S
    Aliment Pharmacol Ther; 2012 Apr; 35(7):789-95. PubMed ID: 22360370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and risk factors of Clostridium difficile infection in patients with inflammatory bowel disease.
    Stoica O; Trifan A; Cojocariu C; Gîrleanu I; Maxim R; Stanciu MC
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):81-6. PubMed ID: 25970947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of Clostridium difficile Infection on Mortality in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Tariq R; Law CCY; Khanna S; Murthy S; McCurdy JD
    J Clin Gastroenterol; 2019 Feb; 53(2):127-133. PubMed ID: 29206751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship.
    Navaneethan U; Venkatesh PG; Shen B
    World J Gastroenterol; 2010 Oct; 16(39):4892-904. PubMed ID: 20954275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
    Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
    Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center.
    Ott C; Girlich C; Klebl F; Plentz A; Iesalnieks I; Schölmerich J; Obermeier F
    Digestion; 2011; 84(3):187-92. PubMed ID: 21646782
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Gillespie W; Marya N; Fahed J; Leslie G; Patel K; Cave DR
    Gastroenterol Res Pract; 2017; 2017():4803262. PubMed ID: 29109735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD.
    Varma S; Faye AS; Kannan A; Lawlor G; Verma A; Axelrad J; Freedberg DE
    Dig Dis Sci; 2021 Sep; 66(9):3113-3123. PubMed ID: 32729015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.
    Wultańska D; Banaszkiewicz A; Radzikowski A; Obuch-Woszczatyński P; Młynarczyk G; Brazier JS; Pituch H; van Belkum A
    Eur J Clin Microbiol Infect Dis; 2010 Oct; 29(10):1265-70. PubMed ID: 20577773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clostridioides difficile Infection in Children With Inflammatory Bowel Disease.
    Chandrakumar A; Zohni H; El-Matary W
    Inflamm Bowel Dis; 2020 Oct; 26(11):1700-1706. PubMed ID: 31765471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Clostridium difficile infection on inflammatory bowel disease outcome: a review.
    Trifan A; Stanciu C; Stoica O; Girleanu I; Cojocariu C
    World J Gastroenterol; 2014 Sep; 20(33):11736-42. PubMed ID: 25206277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.
    Hirten RP; Grinspan A; Fu SC; Luo Y; Suarez-Farinas M; Rowland J; Contijoch EJ; Mogno I; Yang N; Luong T; Labrias PR; Peter I; Cho JH; Sands BE; Colombel JF; Faith JJ; Clemente JC
    Inflamm Bowel Dis; 2019 May; 25(6):969-979. PubMed ID: 30852592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic risk factors for Clostridium difficile infection in ulcerative colitis.
    Ananthakrishnan AN; Oxford EC; Nguyen DD; Sauk J; Yajnik V; Xavier RJ
    Aliment Pharmacol Ther; 2013 Sep; 38(5):522-30. PubMed ID: 23848254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Fischer M; Kao D; Kelly C; Kuchipudi A; Jafri SM; Blumenkehl M; Rex D; Mellow M; Kaur N; Sokol H; Cook G; Hamilton MJ; Phelps E; Sipe B; Xu H; Allegretti JR
    Inflamm Bowel Dis; 2016 Oct; 22(10):2402-9. PubMed ID: 27580384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.